| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0021-9150(02)00242-3 |
| P698 | PubMed publication ID | 12417281 |
| P2093 | author name string | Clemens von Schacky | |
| Peter Angerer | |||
| Stefan Störk | |||
| P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial | Q31825740 | ||
| Cardiovascular disease risk and hormone replacement therapy (HRT): a review based on randomised, controlled studies in postmenopausal women | Q33854192 | ||
| Changing concepts of atherogenesis | Q33890391 | ||
| Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women | Q34067367 | ||
| A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease | Q34105651 | ||
| Clinical practice. Postmenopausal hormone-replacement therapy | Q34300254 | ||
| Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 | ||
| Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality | Q39547122 | ||
| Hormone replacement therapy and increased plasma concentration of C-reactive protein | Q40801238 | ||
| Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. | Q40872170 | ||
| Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study | Q40873641 | ||
| Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women | Q43705626 | ||
| Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study | Q43783590 | ||
| Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study | Q43788768 | ||
| The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women | Q43892904 | ||
| Hormone replacement therapy, heart disease, and other considerations | Q46966284 | ||
| Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study | Q71799117 | ||
| Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study | Q72235431 | ||
| The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study | Q73023222 | ||
| Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women | Q73055289 | ||
| Vascular effects of estrogen and vitamin E therapies in postmenopausal women | Q73142272 | ||
| Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee | Q73321055 | ||
| Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: a randomized 1-year study | Q73372680 | ||
| Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensive patients | Q73802274 | ||
| Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease | Q74020005 | ||
| Effects of estrogen replacement on the progression of coronary-artery atherosclerosis | Q74212886 | ||
| Coronary heart disease in women--an ounce of prevention | Q74212912 | ||
| Effects of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal women | Q74318816 | ||
| Hormone replacement therapy, inflammation, and hemostasis in elderly women | Q77297626 | ||
| Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women | Q77323458 | ||
| Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women | Q77905025 | ||
| Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes | Q78180643 | ||
| P433 | issue | 2 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 301-307 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial | |
| P478 | volume | 165 |
| Q47376712 | "Inflammaging" and Estradiol among Older U.S. Women: A Nationally Representative Longitudinal Study |
| Q35581561 | Adhesion molecules and atherosclerosis |
| Q46472560 | Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy |
| Q42487474 | Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women |
| Q36533649 | Biochemical markers surrogating on vascular effects of sex steroid hormones |
| Q46660405 | Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers |
| Q51131702 | Distinct role of estrogen receptor-alpha and beta on postmenopausal diabetes-induced vascular dysfunction. |
| Q37563372 | Effect of hormone replacement therapy on inflammatory biomarkers. |
| Q44205399 | Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women |
| Q46268406 | Effects of drospirenone on cardiovascular markers in human aortic endothelial cells |
| Q36359547 | Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article |
| Q45929033 | Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetes. |
| Q36086159 | Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. |
| Q46851818 | Estrogen replacement raises rat CRP without evidence of complement activation |
| Q26771644 | Estrogens, inflammation and cognition |
| Q64026758 | Extension of longevity and reduction of inflammation is ovarian-dependent, but germ cell-independent in post-reproductive female mice |
| Q81002469 | Is the WHI relevant to HRT started in the perimenopause? |
| Q46628556 | Mechanism of estrogen-mediated intestinal protection following trauma-hemorrhage: p38 MAPK-dependent upregulation of HO-1. |
| Q36570589 | Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women |
| Q44770881 | Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? |
| Q36826905 | Neighborhood socioeconomic status during childhood versus puberty in relation to endogenous sex hormone levels in adult women |
| Q51785400 | Ovarian hormone status and skeletal muscle inflammation during recovery from disuse in rats. |
| Q37968650 | Primary prevention of cardiovascular disease with HRT. |
| Q44791857 | Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers |
| Q46371055 | Regulatory effects of estrogen on acute lung inflammation in mice |
| Q36346910 | Sexual dimorphism in rodent models of hypertension and atherosclerosis |
| Q90194537 | The Controversial History of Hormone Replacement Therapy |
| Q46447018 | The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women |
| Q46244173 | The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women |
| Q24626206 | Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes |
| Q46945106 | Tissue-specific expression of estrogen receptors and their role in the regulation of neutrophil infiltration in various organs following trauma-hemorrhage |
| Q27011447 | Vascular disease in diabetic women: Why do they miss the female protection? |
| Q37174271 | Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment |
Search more.